PATENT CLAIM ANALYSIS

Application Number: 15762985
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "449000"]

Abstract:
The present invention discloses a water-soluble docetaxel anticancer drug compound having the structure of Formula I below: in which R=—CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , or —CH 2 CH 2 CH 2 CH 3 ; and n=5-500. The active moiety docetaxel in the anticancer drug compound is covalently conjugated to a polyethylene glycol monoalkyl ether through a linker diglycoloyl (carbonyl methoxyacetyl) to form the water-soluble docetaxel anticancer drug compound. The present invention also relates to a preparation method of the drug compound and use thereof.

Claim (Index 1):
A water-soluble docetaxel anticancer drug compound, having the structure of Formula I below: wherein R is C1-C5 alkyl, and n=5-500.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.81818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14438409', '15125543', '14764166', '15520956', '13319175']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7371854532685759
- 35 USC 102 Novelty (BERT): 0.5113619298499619
- Combined Prediction Score: 0.7146031009267144
- Mean Citation Score: 235.69536800000003
- Max Citation Score: 248.05731
- Similarity Product: 171.97251675962448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test